This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Sekisui Chemical Co., Ltd., Nb Health Laboratory Co., Ltd., Ne Health Laboratory Co., Ltd.. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 882 
1 out of 9 
1 out of 1 Years Active: 2014-2016
Title: Akiyoshi Hirayama: Innovator in Therapeutic Antibodies
Introduction
Akiyoshi Hirayama is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of therapeutic antibodies, particularly in the treatment of tissue fibrosis and cancer. With a total of two patents to his name, Hirayama's work is recognized for its innovative approach to medical science.
Latest Patents
Hirayama's latest patents focus on the development of an anti-human CCR7 antibody. This antibody is designed to serve as a therapeutic agent for conditions such as tissue fibrosis and cancer. The invention includes a pharmaceutical composition that contains the anti-human CCR7 antibody, which specifically binds to an extracellular domain of human CCR7. The antibody features a heavy chain CDR3 with specific amino acid sequences, making it a valuable tool in medical treatments. Additionally, the invention encompasses various configurations of the antibody that can interfere with CCR7-dependent intracellular signaling mechanisms.
Career Highlights
Throughout his career, Akiyoshi Hirayama has worked with prominent companies such as Sekisui Chemical Co., Ltd. and Ne Health Laboratory Co., Ltd. His experience in these organizations has contributed to his expertise in the field of therapeutic innovations.
Collaborations
Hirayama has collaborated with notable colleagues, including Naoki Nishiguchi and Masahiro Furutani. These partnerships have further enhanced his research and development efforts in the field of therapeutic antibodies.
Conclusion
Akiyoshi Hirayama's contributions to the field of therapeutic antibodies highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new treatments in the fight against serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile